Article
Bladder Cancer Immunotherapy: BCG and Beyond
Advances in Urology · 2012 · Eric J. Askeland, author Mark R. Newton, author Michael A. O’Donnell, author Yi Luo, author Trinity J. Bivalacqua, Academic Editor
Key facts
| Title | Bladder Cancer Immunotherapy: BCG and Beyond |
|---|---|
| First author | Eric J. Askeland, author Mark R. Newton, author Michael A. O’Donnell, author Yi Luo, author Trinity J. Bivalacqua, Academic Editor |
| Journal | Advances in Urology |
| Published | Mar 16, 2012 |
| DOI | 10.1155/2012/181987 |
| Devices mentioned | K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1